Bong Kook Ko
11Patents
2h-index
25Co-inventors
50Inventor score
Filing activity: May 14, 2014 → Mar 27, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10174116B2 | Antibody specifically binding to HER2 | Chemistry; Metallurgy | 6 | Active |
| US11649294B2 | Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same | Chemistry; Metallurgy | 2 | Active |
| US11970547B2 | Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same | Chemistry; Metallurgy | 1 | Active |
| US12116417B2 | Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same | Physics | 1 | Active |
| US11248059B2 | Antibody having improved stability and specifically binding to HER2 | Chemistry; Metallurgy | 0 | Active |
| US11534462B2 | Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11505603B2 | Anti-TIGIT antibodies and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10465008B2 | Antibodies against vascular endothelial growth factor receptor 2 (VEGFR2), encoding nucleic acid molecules and methods for treating an angiogenesis-related disease | Chemistry; Metallurgy | 0 | Active |
| US12090171B2 | Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11708409B2 | Antibody or antigen-binding fragment thereof that specifically recognizes B cell malignancies, chimeric antigen receptor comprising same, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12410261B2 | Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.